Ibrahim Ayada

864 total citations · 1 hit paper
21 papers, 548 citations indexed

About

Ibrahim Ayada is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Ibrahim Ayada has authored 21 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Hepatology. Recurrent topics in Ibrahim Ayada's work include Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (5 papers) and Inflammatory Bowel Disease (4 papers). Ibrahim Ayada is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (5 papers) and Inflammatory Bowel Disease (4 papers). Ibrahim Ayada collaborates with scholars based in Netherlands, China and United Kingdom. Ibrahim Ayada's co-authors include Qiuwei Pan, Robert J. de Knegt, Laurens A. van Kleef, Louise J. M. Alferink, Pengfei Li, Maikel P. Peppelenbosch, Mohsen Ghanbari, Jiaye Liu, Wanlu Cao and Marco J. Bruno and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Ibrahim Ayada

19 papers receiving 541 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults

2021 147 citations Jiaye Liu, Ibrahim Ayada et al. Clinical Gastroenterology and Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ibrahim Ayada Netherlands	12	393	163	151	103	82	21	548
Yunhao Xun China	13	440 1.1×	117 0.7×	211 1.4×	83 0.8×	87 1.1×	42	566
Somaya Albhaisi United States	13	396 1.0×	131 0.8×	174 1.2×	163 1.6×	59 0.7×	31	558
Johannie du Plessis Belgium	7	416 1.1×	121 0.7×	188 1.2×	96 0.9×	36 0.4×	8	545
Pierre M. Gholam United States	8	376 1.0×	177 1.1×	200 1.3×	59 0.6×	104 1.3×	22	505
Michihiro Iwaki Japan	13	399 1.0×	118 0.7×	196 1.3×	100 1.0×	33 0.4×	44	540
Amanda Wieland United States	8	326 0.8×	112 0.7×	173 1.1×	117 1.1×	63 0.8×	13	434
Esmat Ashour Egypt	10	327 0.8×	117 0.7×	65 0.4×	172 1.7×	35 0.4×	28	579
Egbert Madamba United States	13	717 1.8×	243 1.5×	307 2.0×	219 2.1×	80 1.0×	28	849
Mauro Maurantonio Italy	8	409 1.0×	217 1.3×	179 1.2×	60 0.6×	76 0.9×	11	496
L Franzén Sweden	5	320 0.8×	111 0.7×	152 1.0×	54 0.5×	56 0.7×	6	406

Countries citing papers authored by Ibrahim Ayada

Since Specialization

Citations

This map shows the geographic impact of Ibrahim Ayada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Ayada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Ayada more than expected).

Fields of papers citing papers by Ibrahim Ayada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Ayada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Ayada. The network helps show where Ibrahim Ayada may publish in the future.

Co-authorship network of co-authors of Ibrahim Ayada

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Ayada. A scholar is included among the top collaborators of Ibrahim Ayada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Ayada. Ibrahim Ayada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brouwer, Willem Pieter, et al.. (2025). Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations. World Journal of Gastroenterology. 31(37). 107665–107665.

Li, Jiajing, Jiahua Zhou, Yining Wang, et al.. (2025). The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis. Hepatology Communications. 9(5). 1 indexed citations

Li, Jiajing, Jie Zhou, Ibrahim Ayada, et al.. (2025). Mapping the association between environmental pollutants and steatotic liver disease: a systematic review and meta-analysis. Environmental Research. 285(Pt 5). 122623–122623.

Ayada, Ibrahim, Laurens A. van Kleef, Neil Goulding, et al.. (2024). Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study. SHILAP Revista de lepidopterología. 4(2). 100551–100551. 2 indexed citations

Eerden, Bram C. J. van der, Marijke Schreuders‐Koedam, Jeroen van de Peppel, et al.. (2024). Interaction of high lipogenic states with titanium on osteogenesis. Bone. 188. 117242–117242. 2 indexed citations

Kleef, Laurens A. van, Mesut Savas, Ibrahim Ayada, et al.. (2024). MASLD , At‐Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity. Liver International. 45(4). e16169–e16169. 5 indexed citations

Li, Pengfei, Jiajing Li, Ibrahim Ayada, et al.. (2023). Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks. The Journal of Infectious Diseases. 228(4). 391–401. 27 indexed citations

Kleef, Laurens A. van, Robert J. de Knegt, Ibrahim Ayada, Qiuwei Pan, & Willem Pieter Brouwer. (2023). The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population. Hepatology Communications. 7(4). 18 indexed citations

Ayada, Ibrahim, Laurens A. van Kleef, Qiuwei Pan, et al.. (2023). Plasma proteomic signature of fatty liver disease: The Rotterdam Study. Hepatology. 78(1). 284–294. 13 indexed citations

10.

Wang, Ling, Meng Li, Shaojun Shi, et al.. (2022). Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids. Journal of Molecular Medicine. 100(3). 471–484. 20 indexed citations

11.

Ayada, Ibrahim, Laurens A. van Kleef, Huai Zhang, et al.. (2022). Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study. EBioMedicine. 87. 104392–104392. 66 indexed citations

12.

Li, Jiajing, Ibrahim Ayada, Yining Wang, et al.. (2022). Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation. 106(10). 2068–2075. 23 indexed citations

13.

Liu, Jiaye, Ibrahim Ayada, Xiaofang Zhang, et al.. (2021). Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. Clinical Gastroenterology and Hepatology. 20(3). e573–e582. 147 indexed citations breakdown →

14.

Ayada, Ibrahim, Laurens A. van Kleef, Louise J. M. Alferink, et al.. (2021). Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups. Liver International. 42(2). 277–287. 77 indexed citations

15.

Kleef, Laurens A. van, Ibrahim Ayada, Louise J. M. Alferink, Qiuwei Pan, & Robert J. de Knegt. (2021). Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. Hepatology. 75(2). 419–429. 62 indexed citations

16.

Struys, Eduard A., Ibrahim Ayada, Erwin E. W. Jansen, et al.. (2021). Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study. Inflammatory Bowel Diseases. 28(5). 755–763. 26 indexed citations

17.

Bosch, Sofie, Ibrahim Ayada, Erwin E. W. Jansen, et al.. (2020). Fecal Amino Acid Profiles Exceed Accuracy of Serum Amino Acids in Diagnosing Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 71(3). 371–375. 9 indexed citations

18.

Bosch, Sofie, Ibrahim Ayada, Alfian Wicaksono, et al.. (2019). Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD. Sensors. 19(20). 4496–4496. 15 indexed citations

19.

McCarthy, Neil E., Edward Giles, Ibrahim Ayada, et al.. (2019). P092 Circulating classical monocytes and intestinal macrophages exhibit reduced response to IL-10 in IBD. Journal of Crohn s and Colitis. 13(Supplement_1). S131–S132. 1 indexed citations

20.

McCarthy, Neil E., Charlotte Hedin, Theodore J. Sanders, et al.. (2015). Azathioprine therapy selectively ablates human Vδ2+ T cells in Crohn’s disease. Journal of Clinical Investigation. 125(8). 3215–3225. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact